Canadian Sec - Delayed Quote USD

FLUENT Corp. (FNT-U.CN)

0.0500
0.0000
(0.00%)
At close: May 9 at 1:57:04 PM EDT
Loading Chart for FNT-U.CN
  • Previous Close 0.0500
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.1900
  • Volume 0
  • Avg. Volume 41,737
  • Market Cap (intraday) 31.269M
  • Beta (5Y Monthly) 1.94
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1300
  • Earnings Date May 28, 2025 - Jun 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

FLUENT Corp., through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, concentrates, edibles, and other accessories under the Fluent brand name. It also sells various third-party branded medical cannabis products. The company was formerly known as Cansortium Inc. and changed its name to FLUENT Corp. in February 2025. FLUENT Corp. was incorporated in 2018 and is headquartered in Tampa, Florida.

getfluent.com

826

Full Time Employees

December 31

Fiscal Year Ends

Recent News: FNT-U.CN

View More

Performance Overview: FNT-U.CN

Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

FNT-U.CN
33.33%
S&P/TSX Composite index (^GSPTSE)
3.70%

1-Year Return

FNT-U.CN
71.43%
S&P/TSX Composite index (^GSPTSE)
14.45%

3-Year Return

FNT-U.CN
68.75%
S&P/TSX Composite index (^GSPTSE)
29.61%

5-Year Return

FNT-U.CN
87.01%
S&P/TSX Composite index (^GSPTSE)
71.57%

Compare To: FNT-U.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: FNT-U.CN

View More

Valuation Measures

Annual
As of 5/12/2025
  • Market Cap

    31.27M

  • Enterprise Value

    128.15M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.17

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.24

  • Enterprise Value/EBITDA

    97.98

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -39.00%

  • Return on Assets (ttm)

    3.45%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    103.56M

  • Net Income Avi to Common (ttm)

    -40.39M

  • Diluted EPS (ttm)

    -0.1300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    35.61M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -45.54M

Research Analysis: FNT-U.CN

View More

Company Insights: FNT-U.CN

Research Reports: FNT-U.CN

View More

People Also Watch